Todd Bazemore - 29 Aug 2025 Form 4 Insider Report for KALA BIO, Inc. (KALA)

Role
President and Chief Executive Officer, Director
Signature
/s/ Mary Reumuth, Attorney-in-Fact
Issuer symbol
KALA
Transactions as of
29 Aug 2025
Transactions value $
$0
Form type
4
Filing time
02 Sep 2025, 16:08:52 UTC
Previous filing
26 Jun 2025
Next filing
24 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bazemore Todd President and Chief Executive Officer, Director C/O KALA BIO, INC., 1167 MASSACHUSETTS AVENUE, ARLINGTON /s/ Mary Reumuth, Attorney-in-Fact 02 Sep 2025 0001605767

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KALA Stock Option (right to buy) Award $0 +180K $0.00 180K 29 Aug 2025 Common Stock 180K $11.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on August 29, 2025 and vests over four years beginning on the vesting commencement date of August 29, 2025, with 1/48th of the shares underlying the option vesting at the end of each successive one-month period thereafter until August 29, 2029, subject to the Reporting Person's continued service.

Remarks:

President and Chief Executive Officer